These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16447132)

  • 41. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccine advance-purchase agreements for low-income countries: practical issues.
    Berndt ER; Hurvitz JA
    Health Aff (Millwood); 2005; 24(3):653-65. PubMed ID: 15886157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. U.S. vaccine and immune globulin product shortages, 2001-15.
    Ziesenitz VC; Mazer-Amirshahi M; Zocchi MS; Fox ER; May LS
    Am J Health Syst Pharm; 2017 Nov; 74(22):1879-1886. PubMed ID: 28970246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire survey.
    Gilca V; Boulianne N; Dubé E; Sauvageau C; Ouakki M
    Int J Nurs Stud; 2009 Sep; 46(9):1219-35. PubMed ID: 19349047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Report predicts burgeoning vaccine markets.
    Dove A
    Nat Med; 2001 Aug; 7(8):877. PubMed ID: 11479604
    [No Abstract]   [Full Text] [Related]  

  • 46. Financing vaccines: in search of solutions that work.
    Iglehart JK
    Health Aff (Millwood); 2005; 24(3):594-5. PubMed ID: 15886147
    [No Abstract]   [Full Text] [Related]  

  • 47. Using an immunization information system to improve accountability for vaccines distributed through the Vaccines for Children program in New York City, 2005-2008.
    Metroka AE; Hansen MA; Papadouka V; Zucker JR
    J Public Health Manag Pract; 2009; 15(5):E13-21. PubMed ID: 19704302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine venture boosts health hopes.
    Butler D
    Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588
    [No Abstract]   [Full Text] [Related]  

  • 50. Development pathway for biodefense vaccines.
    Barrett AD; Beasley DW
    Vaccine; 2009 Nov; 27 Suppl 4():D2-7. PubMed ID: 19837280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of the vaccines industry in Mission Grand Convergence.
    Almond J; Medaglini D
    Vaccine; 2017 Jan; 35 Suppl 1():A24-A28. PubMed ID: 28017440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status.
    Jadhav SS; Gautam M; Gairola S
    Biologicals; 2009 Jun; 37(3):165-8. PubMed ID: 19328010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902.
    Lilienfeld DE
    Perspect Biol Med; 2008; 51(2):188-98. PubMed ID: 18453724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, manufacturing and testing of a portable vaccine carrier box employing thermoelectric module and heat pipe.
    Putra N
    J Med Eng Technol; 2009; 33(3):232-7. PubMed ID: 19340694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers.
    Gidengil CA; Rusinak D; Allred NJ; Luff D; Lee GM; Lieu TA
    Clin Pediatr (Phila); 2009 Jun; 48(5):539-47. PubMed ID: 19318705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine shortages: how to cope with a new back-to-school hassle.
    Consum Rep; 2002 Aug; 67(8):8-9. PubMed ID: 12118473
    [No Abstract]   [Full Text] [Related]  

  • 59. Strengthening the supply of routinely administered vaccines in the United States: progress and problems--2005.
    Klein JO; Helms CM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S145-50. PubMed ID: 16447138
    [No Abstract]   [Full Text] [Related]  

  • 60. Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider.
    Orenstein WA; Schaffner W
    Am J Med; 2008 Jul; 121(7 Suppl 2):S22-7. PubMed ID: 18589064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.